These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31291301)

  • 1. A bi-objective game-theoretic model for collaboration formation between software development firms.
    Fahimullah M; Faheem Y; Ahmad N
    PLoS One; 2019; 14(7):e0219216. PubMed ID: 31291301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Extended N-Player Network Game and Simulation of Four Investment Strategies on a Complex Innovation Network.
    Zhou W; Koptyug N; Ye S; Jia Y; Lu X
    PLoS One; 2016; 11(1):e0145407. PubMed ID: 26745375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of product subsidies on R&D investment for new energy vehicle firms: Considering quality preference of the early adopter group.
    Meng W; Wang Y; Li Y; Huang B
    PLoS One; 2020; 15(7):e0236626. PubMed ID: 32735570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-competition, collusion, free riding or coopetition: basins of attraction when firms simultaneously compete and cooperate.
    Pathak S; Pokharel MP; Mahadevan S
    Nonlinear Dynamics Psychol Life Sci; 2013 Jan; 17(1):133-57. PubMed ID: 23244753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments.
    Han E; Kim TH; Jeung MJ; Lee EK
    Clin Ther; 2013 Jul; 35(7):941-9. PubMed ID: 23806327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. University-industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry.
    Tian M; Su Y; Yang Z
    J Technol Transf; 2022; 47(5):1488-1505. PubMed ID: 34456468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
    D'Este P; Tribó JA; García-Romero A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The walking dead: Are Zombie firms environmentally and socially responsible? A global perspective.
    Mashwani AI; Mushtaq R; Gull AA; Rind AA
    J Environ Manage; 2024 Mar; 355():120499. PubMed ID: 38461638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Investment Projects of Spinal Medical Device Firms Using the Real Option and DANP-mV Based MCDM Methods.
    Huang CY; Hsieh HL; Chen H
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32403356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the model for risk-informed regulation be game theory rather than decision theory?
    Bier VM; Lin SW
    Risk Anal; 2013 Feb; 33(2):281-91. PubMed ID: 22908942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Guidance' or 'Misleading'? The government subsidy and the choice of enterprise innovation strategy.
    Ding J; Wang J; Liu B; Peng L
    Front Psychol; 2022; 13():1005563. PubMed ID: 36267081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Invest or Not to Invest, That Is the Question: Analysis of Firm Behavior under Anticipated Shocks.
    Kovac D; Vukovic V; Kleut N; Podobnik B
    PLoS One; 2016; 11(8):e0158782. PubMed ID: 27508896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on U-shaped relationship between short-term debt for long-term use and supply chain enterprise default risk: Evidence from Chinese listed firms.
    Shen H; Chen J
    PLoS One; 2023; 18(10):e0293284. PubMed ID: 37871103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing decisions in private family firms: a family firm pecking order.
    Jansen K; Michiels A; Voordeckers W; Steijvers T
    Small Bus Econ (Dordr); 2022 Dec; ():1-21. PubMed ID: 38625293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Concerns, Environmental Policy and Green Investment.
    Gao X; Zheng H
    Int J Environ Res Public Health; 2017 Dec; 14(12):. PubMed ID: 29236072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of infectious medical waste disposal firms by using the analytic hierarchy process and sensitivity analysis.
    Hsu PF; Wu CR; Li YT
    Waste Manag; 2008; 28(8):1386-94. PubMed ID: 17689065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Do Heterogeneous Networks Affect a Firm's Innovation Performance? A Research Analysis Based on Clustering and Classification.
    Zhang L; Qiu H; Chen J; Zhou W; Li H
    Entropy (Basel); 2023 Nov; 25(11):. PubMed ID: 37998252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-regional collaborative governance in the process of pollution industry transfer: The case of enclave parks in China.
    Li J; Wang J; Lee H; Zhao X
    J Environ Manage; 2023 Mar; 330():117113. PubMed ID: 36584461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating firm digitalization: A method for disaggregating sector-level digital intensity to firm-level.
    Mucha T; Seppälä T
    MethodsX; 2021; 8():101233. PubMed ID: 34434756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.